Posttranscriptional deregulation of src due to aberrant miR34a and miR203 contributes to gastric cancer development

BMB Reports

Volumn 46, Issue 6, 2013, Pages 316-321

  Hao, Qiang ^a   Lu, Xiaozhao ^b   Liu, Nannan ^a   Xue, Xiaochang ^a   Li, Meng ^a   Zhang, Cun ^a   Qin, Xin ^a   Li, Weina ^a   Shu, Zhen ^a   Song, Bin ^c   Wang, Qing ^c   Song, Liqiang ^d   Zhang, Wei ^a   Zhang, Yingqi ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b The 323 Hospital of PLA   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; MiR203; MiR34a; MiRNA; Src

Indexed keywords

MESSENGER RNA; MICRORNA; MIRN203 MICRORNA, HUMAN; MIRN34 MICRORNA, HUMAN; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ARTICLE; CELL MOTION; CELL PROLIFERATION; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; PATHOLOGY; RNA INTERFERENCE; STOMACH TUMOR; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MICRORNAS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; STOMACH NEOPLASMS;

EID: 84880634169     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.6.208     Document Type: Article

References (24)

1. Siegel, R., Naishadham, D. and Jemal, A. (2012) Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29.
2. Le, X. F. and Bast, R. C. Jr. (2011) Src family kinases and paclitaxel sensitivity. Cancer Biol. Ther. 12, 260-269.
3. Aleshin, A. and Finn, R. S. (2010) SRC: a century of science brought to the clinic. Neoplasia 12, 599-607.
4. Wheeler, D. L., Iida, M. and Dunn, E. F. (2009) The role of Src in solid tumors. Oncologist 14, 667-678.
5. Ishizawar, R. and Parsons, S. J. (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6, 209-214.
6. Yang, G., Fu, H., Zhang, J., Lu, X., Yu, F., Jin, L., Bai, L., Huang, B., Shen, L., Feng, Y., Yao, L. and Lu, Z. (2010) RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer. Gastroenterology 138, 231-240, e231-235.
7. Wightman, B., Ha, I. and Ruvkun, G. (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855-862.
8. Lee, R. C., Feinbaum, R. L. and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854.
9. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
10. Calin, G. A. and Croce, C. M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866.
11. Esquela-Kerscher, A. and Slack, F. J. (2006) Oncomirs microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
12. Kato, M., Paranjape, T., Muller, R. U., Nallur, S., Gillespie, E., Keane, K., Esquela-Kerscher, A., Weidhaas, J. B. and Slack, F. J. (2009) The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28, 2419-2424.
13. Roy, S., Levi, E., Majumdar, A. P. and Sarkar, F. H. (2012) Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J. Hematol. Oncol. 5, 58.
14. Kasinski, A. L. and Slack, F. J. (2012) miRNA-34 prevents cancer initiation and progression in a therapeutically-resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res. 72, 5576-5587.
15. Wang, C., Zheng, X., Shen, C. and Shi, Y. (2012) MicroRNA203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. J. Exp. Clin. Cancer Res. 31, 58.
16. Summy, J. M. and Gallick, G. E. (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 22, 337-358.
17. Okamoto, W., Okamoto, I., Yoshida, T., Okamoto, K., Takezawa, K., Hatashita, E., Yamada, Y., Kuwata, K., Arao, T., Yanagihara, K., Fukuoka, M., Nishio, K. and Nakagawa, K. (2010) Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition. Mol. Cancer Ther. 9, 1188-1197.
18. Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P. and Bartel, D. P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105.
19. Garofalo, M., Romano, G., Di Leva, G., Nuovo, G., Jeon, Y. J., Ngankeu, A., Sun, J., Lovat, F., Alder, H., Condorelli, G., Engelman, J. A., Ono, M., Rho, J. K., Cascione, L., Volinia, S., Nephew, K. P. and Croce, C. M. (2012) EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat. Med. 18, 74-82.
20. Saini, S., Arora, S., Majid, S., Shahryari, V., Chen, Y., Deng, G., Yamamura, S., Ueno, K. and Dahiya, R. (2011) Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Cancer Prev. Res. (Phila) 4, 1698-1709.
21. Li, N., Tang, B., Zhu, E. D., Li, B. S., Zhuang, Y., Yu, S., Lu, D. S., Zou, Q. M., Xiao, B. and Mao, X. H. (2012) Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett. 586, 722-728.
22. Zauli, G., Voltan, R., di Iasio, M. G., Bosco, R., Melloni, E., Sana, M. E. and Secchiero, P. (2011) miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. Clin. Cancer Res. 17, 2712-2724.
23. Yang, G., Lu, X., Wang, L., Bian, Y., Fu, H., Wei, M., Pu, J., Jin, L., Yao, L. and Lu, Z. (2011) E2F1 and RNA binding protein QKI comprise a negative feedback in the cell cycle regulation. Cell Cycle 10, 2703-2713.
24. Oukka, M., Wein, M. N. and Glimcher, L. H. (2004) Schnurri-3 (KRC) interacts with c-Jun to regulate the IL-2 gene in T cells. J. Exp. Med. 199, 15-24.